News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells
Adaptive Biotechnologies and Microsoft announced a new project to address COVID-19, called ImmuneCODE. The project tracks how the immune system fights COVID-19 and aims to
Seattle biotech firm scores $85 million for work on Alzheimer’s drug, despite hurdles of coronavirus pandemic
Athira Pharma, a Seattle-based biotechnology company, secured $85 million in a Series B round. The additional financing will support Athira Pharma’s Phase 2/3 Alzheimer’s clinical
‘Start innovating like crazy’: Fast-moving genomics startup turns to R&D to navigate the pandemic
Phase Genomics, a Seattle-based life science company, that maps and analyzes genomes, is focusing its attention inward and renewing its R&D efforts during the pandemic.
Seattle Children’s Hospital and Prevencio: The Hunt to Understand COVID-19’s Connection to Kawasaki Disease
Seattle Children’s Hospital is working with blood-testing startup Prevencio to develop a blood test to detect certain proteins and blood components leading to a firm
Seattle researchers building ‘biobank’ of patients’ blood to unlock the mysteries of the new coronavirus
The Institute for Systems Biology (ISB) and Swedish Health are building a “biobank” to study COVID-19’s impact on the human body. According to Dr. Jim
Nautilus emerges with $76M to become the ‘Illumina of proteomics’
Seattle headquartered, Nautilus Biotechnology announced a $76 million series B round to fund its work analyzing and quantifying the human proteome. Nautilus Biotechnology is looking